Five new crystalline gold(I) complexes β-Au(μ-dppm)Br·2CHCl (), [Au(μ- dppm)Br]Br·2CHCl (), [Au(μ-dppm)Br](PF) (), [Au(μ-dppm)Cl](BPh)·3CHCl () and [Au(μ-dppm)]Cl(AsF)·2CHCl () (where dppm is bis(diphenylphosphino)methane) have been prepared and structurally characterized by single crystal X-ray diffraction. Colorless β-Au(μ-dppm)Br·2CHCl () has centrosymmetric structure with two three-coordinate gold(I) ions held in close proximity by the dppm ligands. Crystals of [Au(μ- dppm)Br]Br·2CHCl (), [Au(μ-dppm)Br](PF) (), and [Au(μ-dppm)Cl](BPh)·3CHCl () have a cation with an unusual arrangement that binds a two-coordinate gold(I) ion to a three-coordinate gold(I) ion through an aurophilic interaction.
View Article and Find Full Text PDFBackground: Patients undergoing primary percutaneous coronary intervention (PPCI) for ST-segment-elevation myocardial infarction (STEMI) have a high thrombotic burden and often have a high bleeding risk (HBR). Asian patients have different patterns of thrombotic and bleeding risk from other populations which may be particularly relevant in the setting of PPCI for STEMI.
Objectives: To assess the safety and efficacy of the polymer free biolimus coated coronary stent (PF-BCS, BioFreedom, Biosensors International) in Asian STEMI patients.
Objective: Describe continuous infusion (CI) ketamine practices in pediatric intensive care units (PICUs) and evaluate its effect on pain/sedation scores, exposure to analgesics/sedatives, and adverse effects (AEs).
Methods: Multicenter, retrospective, observational study in children <18 years who received CI ketamine between 2014 and 2017. Time spent in goal pain/sedation score range and daily cumulative doses of analgesics/sedatives were compared from the 24 hours (H) prior to CI ketamine to the first 24H and 25-48H of the CI.